Log in

NYSE:GRXGabelli Healthcare & WellnessRx Trust Closed-Ended Fund Stock Price, Forecast & News

$10.65
+0.01 (+0.09 %)
(As of 08/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$10.60
Now: $10.65
$10.73
50-Day Range
$9.94
MA: $10.25
$10.67
52-Week Range
$6.85
Now: $10.65
$11.92
Volume53,547 shs
Average Volume60,645 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.05%
BetaN/A
The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Investment Trusts/Mutual Funds
Sub-IndustryN/A
CUSIPN/A
Phone914-921-5000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
$10.65
+0.01 (+0.09 %)
(As of 08/10/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GRX News and Ratings via Email

Sign-up to receive the latest news and ratings for GRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund (NYSE:GRX) Frequently Asked Questions

How has Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's stock been impacted by COVID-19 (Coronavirus)?

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's stock was trading at $9.45 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, GRX stock has increased by 12.7% and is now trading at $10.65.
View which stocks have been most impacted by Coronavirus
.

How often does Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund pay dividends? What is the dividend yield for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund?

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund announced a quarterly dividend on Friday, May 15th. Stockholders of record on Tuesday, June 16th will be paid a dividend of $0.14 per share on Tuesday, June 23rd. This represents a $0.56 dividend on an annualized basis and a dividend yield of 5.26%. The ex-dividend date of this dividend is Monday, June 15th.
View Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's dividend history
.

Has Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund been receiving favorable news coverage?

News headlines about GRX stock have been trending positive on Tuesday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund earned a media sentiment score of 2.8 on InfoTrie's scale. They also assigned news coverage about the investment management company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future.
View the latest news about Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund
.

Are investors shorting Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund?

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 2,500 shares, an increase of 31.6% from the December 15th total of 1,900 shares. Based on an average daily trading volume, of 32,000 shares, the days-to-cover ratio is presently 0.1 days.
View Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's Short Interest
.

Who are some of Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's key competitors?

What other stocks do shareholders of Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund investors own include Gabelli Equity Trust (GAB), Cisco Systems (CSCO), Park City Group (PCYG), AT&T (T), AbbVie (ABBV), Cohen & Steers Clsd-End Optuny Fnd (FOF), General Electric (GE), Gilead Sciences (GILD), Johnson & Johnson (JNJ) and KeyCorp (KEY).

Who are Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's key executives?

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's management team includes the following people:
  • Mr. Wayne Christopher Pinsent CFA, Assistant VP and Ombudsman (Age 33)
  • Mr. Mario Joseph Gabelli C.F.A., CFA, Portfolio Mang. (Age 76)
  • Ms. Agnes Nora Mullady, Pres & Chief Operating Officer of the Open-End Fund Division & VP (Age 60)
  • Mr. Richard John Walz, Chief Compliance Officer (Age 60)
  • Mr. Bruce N. Alpert C.P.A., CPA, Exec. VP & Chief Operating Officer (Age 67)

What is Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's stock symbol?

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund trades on the New York Stock Exchange (NYSE) under the ticker symbol "GRX."

Who are Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's major shareholders?

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Raymond James & Associates (0.00%), UBS Group AG (0.00%), Aviance Capital Partners LLC (0.00%), Blue Bell Private Wealth Management LLC (0.00%), Matisse Capital (0.00%) and Janney Montgomery Scott LLC (0.00%). Company insiders that own Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund stock include James P Conn, Mario J Gabelli and Salvatore J Zizza.
View institutional ownership trends for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund
.

Which major investors are selling Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund stock?

GRX stock was sold by a variety of institutional investors in the last quarter, including Janney Montgomery Scott LLC.
View insider buying and selling activity for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund
.

Which major investors are buying Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund stock?

GRX stock was acquired by a variety of institutional investors in the last quarter, including UBS Group AG, Blue Bell Private Wealth Management LLC, Aviance Capital Partners LLC, Matisse Capital, Raymond James & Associates, and Mid Atlantic Financial Management Inc. ADV.
View insider buying and selling activity for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund
.

How do I buy shares of Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund?

Shares of GRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's stock price today?

One share of GRX stock can currently be purchased for approximately $10.65.

What is Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's official website?

The official website for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund is www.gabelli.com.

How can I contact Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund?

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's mailing address is 1 Corporate Ctr, RYE, NY 10580-1485, United States. The investment management company can be reached via phone at 914-921-5000.

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.